Research Article

Granulovacuolar Degeneration in Hippocampus of Neurodegenerative Diseases: Quantitative Study

Table 4

(a) and (b) show GVD at CA2 in neurodegenerative and control cases.
(a) GVD at CA1 sector in neurodegenerative and control cases. Dependent Variable: t_CA1. For AD and AD/LBD , <0.05

CasesADAD/LBDAGDCBDControlFTLDLBDMSAPDPSPPiD

AD1.00001.00000.9886<0.00010.00020.00170.47120.04010.7808
AD/LBD1.00001.00000.98890.01180.01610.17750.01410.55330.23730.7948
AGD1.00001.00001.00000.97270.87540.98430.69680.98300.99010.9928
CBD0.98860.98891.00000.99450.93180.99820.76440.99780.99930.9994
Control<0.00010.01180.97270.99450.99691.00000.93061.00001.00001.0000
FTLD0.00020.01610.87540.93180.99690.99970.99991.00000.99901.0000
LBD0.02230.17750.98430.99821.00000.99970.97921.00001.00001.0000
MSA0.00170.01410.69680.76440.93060.99990.97920.99990.96390.9999
PD0.47120.55330.98300.99781.00001.00001.00000.99991.00001.0000
PSP0.04010.23730.99010.99931.00000.99901.00000.96391.00001.0000
PiD0.78080.79480.99280.99941.00001.00001.00000.99991.00001.0000

(b) GVD at CA2 sector in neurodegenerative and control cases. Dependent Variable: t_CA2. For AD , <0.05 and AD/LBD , <0.05

CasesADAD/LBDAGDCBDControlFTLDLBDMSAPDPSPPiD

AD0.94381.00001.00000.02870.45691.00000.99110.99551.00000.9992
AD/LBD0.94380.99980.99890.04990.13110.96290.74540.84780.96450.9455
AGD1.00000.99981.00000.99970.99811.00001.00001.00001.00001.0000
CBD1.00000.99891.00000.99100.97371.00000.99970.99961.00000.9999
Control0.02870.04990.99970.99101.00000.94871.00001.00000.94561.0000
FTLD0.45690.13110.99810.97371.00000.92881.00001.00000.92591.0000
LBD1.00000.96291.00001.00000.94870.92880.99970.99971.00000.9999
MSA0.99110.74541.00000.99971.00001.00000.99971.00000.99961.0000
PD0.99550.84781.00000.99961.00001.00000.99971.00000.99961.0000
PSP1.00000.96451.00001.00000.94560.92591.00000.99960.99960.9999
PiD0.99920.94551.00000.99991.00001.00000.99991.00001.00000.9999